Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case!
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Pfizer 1st shot yesterday, Kingsport, TN, USA

2 years ago

Kingsport, Tennessee, United States

I got the Pfizer shot yesterday at Walgreens. I will return in 3 weeks to get the second dose. I just had a slight headache and a bit of soreness in the arm. That being said I am sure it is better than get COVID. | Symptoms: Headache, Soreness

87


Related Reports

I got this covid booster, and flu shot at the same time. Zero side effects so far, and I am on day 3 now. I assume by now I am in the clear. The picture says moderna, but he assured me it was the pfizer. See Less
544


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples. The product lot... See More was distributed nationwide to wholesalers/hospitals in the United States from July 16, 2020 through July 24, 2020. To date, Pfizer has not received reports of any adverse events associated with this issue for this lot.

Risk Statement: Patients receiving the impacted product have a remote probability of experiencing potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial. The NDC, Lot Number, Expiration Date, and Configuration details for Propofol Injectable Emulsion are indicated below.

Product: Configuration/Count Propofol Injectable Emulsion, 100 mL Single Patient Use Glass Fliptop Vial
NDC: Vial: 0409-4699-54 Tray: 0409-4699-24
Lot Number: EA7470
Expiration Date: 01 JUNE 2023
Presentation: 1g/100 mL, Single Patient Use Glass Fliptop Vial
Configuration/Count: Tray of 10 Units

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira, Inc., a Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: August 22, 2022

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-propofol-injectable-emulsion-containing-benzyl
See Less
303


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a visible particulate observed in a single vial during annual examination of retain... See More samples. The product lot was distributed nationwide to wholesalers/ hospitals/Department of Defense in the United States from June 10, 2020 through June 26, 2020.

The recalled product is:
- Propofol Injectable Emulsion, USP 100 mL Single Patient Use Glass Fliptop Vial, NDC: Vial: 0409-4699-54 Carton: 0409-4699-24, Lot Number: DX9067, Expiration Date Presentation: 01 MAY 2023, Configuration/Count: 1 g/100 mL, Single Patient Use Glass Fliptop Vial Case of 10 Units.

Risk Statement: Patients receiving the impacted product are at risk of experiencing life-threatening adverse clinical effects including but not limited to: blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

To date, Hospira, Inc. has not received reports of any adverse events associated with this issue for this lot. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion, USP is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a single patient use fliptop vial.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should stop use and distribution and quarantine immediately. If you have further distributed the recalled product, to the wholesale or hospital level/institution, please notify any accounts or additional locations which may have received the recalled product from you. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira Inc, A Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: July 13, 2022

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-propofol-injectable-emulsion-usp-containing
See Less
303


Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level.... See More To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. 

Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

These products are indicated for the treatment of hypertension.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The products have a safety profile that has been established over 20 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data. Although long term ingestion of N-nitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication. Patients currently taking the products should consult with their doctor about alternative treatment options.

The NDC, Lot Number, Expiration Date, and Configuration details for these products are indicated in the tables in the link below and photos of the products can be found below. The product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from November 2019 to March 2022.

- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
- quinapril and hydrochlorothiazide tablets, 20/25 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers and distributors with an existing inventory of the lots, listed in the table above, should stop use and distribution and quarantine the product immediately.

If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you.

Company name: Pfizer
Brand name: Accuretic, Greenstone Brand
Product recalled: Accuretic™ (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets
Reason of the recall: Presence of a nitrosamine, N-nitroso-quinapril
FDA Recall date: March 22, 2022

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-voluntary-nationwide-recall-lots-accuretictm-quinapril-hclhydrochlorothiazide-quinapril-and
See Less
303


This group fronted as QVC but turned out to be a scam. Called tjmaxx card synchrony immediately, told them about fraud on the same day ordered, told them not to pay them. They request report cart as stolen and they would not pay charge. When synchrony transferred... See More account to ne card, they transfer this scam payment. We are being forced to pay someone for no goods received. I want my money back. And won't these folks stopped. See Less
89


Sad to report this is the 4th time having problems with the Kingsport TN Popeyes. Three previous attempts at the drive through we tried to order a 8 piece bucket chicken only. Two times they said we would have a 20 minute wait which we were not... See More expecting. On the third trip I asked for an 8 piece and the lady said there would be a twenty minute wait so I asked for an additional order of two drumsticks non spicy and she said it would 30 minutes. I responded with “are you kidding me.” We left. Well tonight, Jan 18, 2023, we preordered our chicken online to be ready at 8:07pm. We arrived there at 8:09 and there was a car placing an order. I figured all I need to do is proceed to the window which I did. The car that was ordering drove by us about 3 minutes later, I assume it was one having to wait 20 minutes for their order but decided not to wait. We sat there at the window and no one was there for 5 minutes, that includes the front registers in the restaurant as well. Just after that an employee walks by and looks at me directly in the eyes as I was waiving for her and she keeps going about her business. Not one word. I start knocking on the window and no one responds. About 4 mins later I wave at the same lady and she comes to the window and says she is busy helping other customers, while no one else was behind me, and closes the window before I could tell her we had a togo order. 3 or 4 minutes later she came back to the window and started telling me in a frustrated louder voice that “you need to stop at the box, you need to stop at the box.” I said we were here for a togo order but she kept saying “you have to stop at the box.” I am thinking this is ridiculous and told her when she locked eye with me that she did not even acknowledge my existence. She would not get off stopping at the box so I said we are here to pick up or order. Not sure what company policy is but whether I stop at the box or not when picking up my order and an employee sees me I expect acknowledgment by nodding a head, throwing up an index finger meaning just a minute. I was not expecting to argue with a Popeyes employee whether I stopped at the box or not. Best scenario would have been the employee brush off the attitude open the window and say something like “hi, ever ordered off the app before.” That way she would have known this is our first time and explained us Popeyes policy or if was her policy. The Popeyes website does not indicate having to stop at the box first so, anyway. After these four issues when dealing with Popeyes we have decided to not visit that store ever again. Seems as if these days employers hire people that should be better at customer service. Just to say, I am one of those guys that believe the customer is not always right but in this case of very poor customer service I know I am right. I have a Master Degree in Business Administration with a Concentration in Human Resources and have studied this kind of behavior on the job and have faced many different scenarios. Employees like this poison the other employees and if I was the Manager she would be counseled and if future infractions take place termination of employment would be very likely. No receipt was provided, this may be because I told her I was going to contact the corporate office. See Less
88


A Package came in the mail that contains a USB port and attached wires With insert ports at each end of the wire. The main color is a mint green and there is purple and pink. See Less
87


I did not but received a knee brace in the mail. What I did order was supposed to be a rocking outdoor chair from what I thought was QVC😤. If this is a scam shame on you😱. I want my money back OR I want the chair.... See More I paid for and ordered in good faith a rocking outdoor chair. Instead I received a knee brace😱😤 See Less
87


Recent Interesting Reports

I haveI keep receiving 2 bottles of gummy’s every month , did not order for every month and want to cancel please. Acv for keto health P.O. Box 81827 Las Vegas Nevada 89180, Order #C4AF23****

#scam #ketogummiesscam #subscriptionscam #lasvegas #nevada See Less
539


I received the birdie product and looked it up on Google to find out what it was and got this page to report it so that's what I done. See Less
146


I am reporting a package I received but did not order. It is verti bio. I don’t know how they got my name and address. It’s for weight loss and energy See Less
37


DGT GOODSGONS SINGAPORE SG, I bought shoes at the beginning of February.$93 was withdrawn from my credit card.they did not send the item.unfortunately I was scammed. See Less


I ordered a rechargeable torch that was supposed to be $29.99 and was charged $59.98 just got it today and received a butane lighter and some ear cleaners? See Less
284


Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product... See More solution. The lot was distributed nationwide to wholesalers and hospitals from June 16, 2022, through October 17, 2022. To date, Par has not received any reports of adverse events related to this recall.

Administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs, or brain which can cause stroke and even lead to death.

Treprostinil Injection is formulated for subcutaneous or intravenous infusion. The product is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise and for patients who require a transition from epoprostenol to reduce the rate of clinical deterioration.

Treprostinil Injection 20mg/20mL (1mg/mL) is distributed in 20mL multidose vials as sterile solutions in water for injection, individually packaged in cartons under NDC #42023-206-01. Only Lot 57014, expiration date 04/2024 is affected by this recall. Vials from the affected lot bear the attached label.

Par is providing written notification to wholesale accounts and the hospital location that has received the affected lot and is arranging for the return of all existing inventory of Lot 57014 through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product being recalled should immediately discontinue the use and stop distribution immediately.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Endo International, Par Pharmaceutical
Brand name: Par Pharmaceutical
Product recalled: Treprostinil 20mg/20mL Injection
Reason for the recall: Potential Presence of Silicone Particulate Matter
FDA Recall date: March 12, 2024

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-pharmaceutical-issues-voluntary-nationwide-recall-one-lot-treprostinil-injection-due-potential
See Less
303


Pkg came by USPS  did not order. Has Hazmat service transportation surface only.  Return to Jerry (001) Yasfbara 9208 Charles Smith Ave,Rancho Cucamonga ca91730.
I am returning. USPS tracking#9261292700545500070020****

Im in Fair Oaks, CA, USA See Less
702


Last 30 days